Description of Medical Areas
About the FDA Approved Listings
|
 |
Approved Drugs for Musculoskeletal
Drugs Approved in 2008
Orencia (abatacept); For the treatment of Juvenile Idiopathic Arthritis; Bristol-Myers Squibb; Approved April 2008
Drugs Approved in 2007
Evista (raloxifene hydrochloride); For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women; Eli Lilly; Approved September 2007
Reclast (zoledronic acid); For the treatment of postmenopausal osteoporosis; Novartis; Approved August 2007
Reclast (zoledronic acid); For the treatment of Paget's disease; Novartis Pharms; Approved April 2007
Drugs Approved in 2006
No approvals recorded for Musculoskeletal in 2006.
Drugs Approved in 2005
Naglazyme (galsulfase); For the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome); BioMarin Pharmaceuticals; Approved May 2005
Drugs Approved in 2004
No approvals recorded for Musculoskeletal in 2004.
Drugs Approved in 2003
Aldurazyme (laronidase); For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65; Genzyme; Approved May 2003
Boniva (ibandronate); For the treatment and prevention of osteoporosis; Roche / GlaxoSmithKline; Approved May, 2003 -- UPDATED: NEW FORMULATION APPROVED MARCH, 2005
Somavert (pegvisomant); Injectable formulation for the treatment of acromegaly; Pharmacia; Approved March 2003
Velcade (bortezomib); Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies.; Millennium Pharmaceuticals; Approved May 2003
Drugs Approved in 2002
Alora; Transdermal patch for the prevention of postmenopausal osteoporosis and treatment of vasomotor menopausal symptoms; Watson Pharmaceuticals; Approved April 2002
Avinza (morphine sulfate); Extended release capsule for the relief of pain requiring continuous, around-the-clock therapy; Elan; Approved March 2002
Forteo (teriparatide); For the treatment of Osteoporosis in postmenopausal women and men who are at high risk for a fracture.; Eli Lilly; December 2002
Remicade; Intravenous infusion for the treatment of rheumatoid arthritis; Centocor; Approved February 2002
Testim; External cream for the treatment of male hormone deficiency.; Auxilium Pharmaceuticals; Approved October 2002
Vioxx (rofecoxib); For the treatment of rheumatoid arthritis; Merck; Approved April 2002 -- UPDATED: WITHDRAWN OCTOBER 2004
Drugs Approved in 2001
Genotropin (somatropin); For the treatment of growth failure in children who were born small for gestational age (SGA); Pharmacia; Approved July 2001
Kineret; Injectable therapy for the treatment of rheumatoid arthritis; Amgen; Approved November 2001
Supartz; Joint fluid therapy for treatment of osteoarthritis in the knee; Smith & Nephew Orthopaedics; Approved January 2001
Drugs Approved in 2000
Activella (Estradiol/Norethindrone Acetate) Tablets; Combination hormone replacement therapy for the prevention of osteoporosis and other symptoms associated w/postmenopause; Novo Nordisk; Approved April 2000
Mobic (meloxicam) Tablets; For relief of the signs and symptoms of osteoarthritis; Boehringer Ingelheim; Approved April 2000
Myobloc; Injectable solution for the treatment of abnormal head position and neck pain associated with cervical dystonia; Elan; Approved December 2000
Drugs Approved in 1999
Evista; Osteoporosis treatment; Eli Lilly; Approved September 1999
Femhrt Tablets; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg); Parke-Davis; October 15, 1999
Drugs Approved in 1998
Actonel; Treatment for Paget's Disease; Procter & Gamble, Hoechst Marion Roussel; Approved April 1998
Estratab (.3 mg ); Treatment for the prevention of osteoporosis; Solvay Pharmaceuticals; Approved March 1998
Etodolac tablets; Generic equivalent of Lodine 500 mg tablets; Faulding; Approved May 1998
Lodine XL; Treatment for arthritis; Wyeth-Ayerst Laboratories; Approved February 1998
Lovenox; Treatment for prevention of blood clots following hip-replacement surgery; Rhone Poulenc Rorer; Approved February 1998
Drugs Approved in 1997
Arthrotec; Treatment for arthritis; Searle; Approved December 1997
Atracurium Besylate Injection; Generic equivalent of Tracrium; Faulding; Approved April 1997
Estradiol Tablets USP; Generic equivalent of Estrace; Barr Laboratories; Approved October 1997
Etodolac 200mg and 300mg; Generic equivalent of Lodine; Royce Laboratories; Approved December 1997
Evista; Treatment for the prevention of osteoporosis; Eli Lilly; Approved December 1997
Ketoprofen; Generic equivalent or Oruvail; Schein Pharmaceutical; Approved December 1997
Skelid (tiludronate disodium); Treatment for Paget’s disease of bone; Sanofi Pharmaceuticals; Approved March 1997
Tolmetin Sodium; Treatment for arthritis; Teva Pharmaceutical; Approved March 1997
Drugs Approved in 1996
Kadian; Treatment for chronic moderate to severe pain; Purepac Pharmaceutical; Approved July 1996
Naprelan (naproxen sodium); Treatment for osteoarthritis and rheumatoid arthritis; Elan, Wyeth-Ayerst Laboratories; Approved January 1996
OxyContin (oxycodone HCl controlled-release); Treatment for pain associated with musculoskeletal conditions; Purdue Pharma; Approved May 1996
Saizen; Treatment for growth hormone deficiency and Turner Syndrome; Ares-Serono; Approved May 1996
Seprafilm; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery; Genzyme; Approved August 1996
Drugs Approved in 1995
Fosamax (alendronate sodium); Treatment for osteoporosis in women after menopause and Paget's Disease of Bone; Merck; Approved on September 29, 1995
|
|
Back to Centerwatch Drug Approvals
|
